Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 231.0
(0.87%)
JPY 231.0
(0.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 100.52 Million JPY | -27.04% |
| 2022 | 137.79 Million JPY | 6.7% |
| 2021 | 129.13 Million JPY | -24.57% |
| 2020 | 171.2 Million JPY | 3.48% |
| 2019 | 165.43 Million JPY | -12.1% |
| 2018 | 188.2 Million JPY | -44.32% |
| 2017 | 338.01 Million JPY | -55.01% |
| 2016 | 751.32 Million JPY | -32.25% |
| 2015 | 1.1 Billion JPY | -18.37% |
| 2014 | 1.35 Billion JPY | -12.57% |
| 2013 | 1.55 Billion JPY | -16.5% |
| 2012 | 1.86 Billion JPY | 12.25% |
| 2011 | 1.65 Billion JPY | 12.7% |
| 2010 | 1.47 Billion JPY | -10.89% |
| 2009 | 1.65 Billion JPY | 5580.12% |
| 2008 | 29.06 Million JPY | 0.0% |
| 2007 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 100 Million JPY | -0.53% |
| 2023 Q3 | 100 Million JPY | 0.0% |
| 2023 Q4 | 100.52 Million JPY | 0.53% |
| 2023 Q1 | 100 Million JPY | -27.43% |
| 2023 FY | 100.52 Million JPY | -27.04% |
| 2023 Q2 | 100 Million JPY | 0.0% |
| 2022 Q1 | 100 Million JPY | -22.56% |
| 2022 FY | 137.79 Million JPY | 6.7% |
| 2022 Q4 | 137.79 Million JPY | 37.79% |
| 2022 Q3 | 100 Million JPY | 0.0% |
| 2022 Q2 | 100 Million JPY | 0.0% |
| 2021 Q2 | 100 Million JPY | 0.0% |
| 2021 Q4 | 129.13 Million JPY | 29.14% |
| 2021 Q3 | 100 Million JPY | 0.0% |
| 2021 FY | 129.13 Million JPY | -24.57% |
| 2021 Q1 | 100 Million JPY | -41.59% |
| 2020 Q4 | 171.2 Million JPY | 71.2% |
| 2020 Q1 | 100 Million JPY | -39.55% |
| 2020 Q2 | 100 Million JPY | 0.0% |
| 2020 Q3 | 100 Million JPY | 0.0% |
| 2020 FY | 171.2 Million JPY | 3.48% |
| 2019 Q4 | 165.43 Million JPY | 65.44% |
| 2019 FY | 165.43 Million JPY | -12.1% |
| 2019 Q3 | 100 Million JPY | 0.0% |
| 2019 Q2 | 100 Million JPY | 0.0% |
| 2019 Q1 | 100 Million JPY | -46.87% |
| 2018 Q3 | 180 Million JPY | -18.18% |
| 2018 FY | 188.2 Million JPY | -44.32% |
| 2018 Q4 | 188.2 Million JPY | 4.56% |
| 2018 Q2 | 220 Million JPY | -15.38% |
| 2018 Q1 | 260 Million JPY | -23.08% |
| 2017 Q4 | 338.01 Million JPY | -0.59% |
| 2017 FY | 338.01 Million JPY | -55.01% |
| 2017 Q3 | 340 Million JPY | -10.53% |
| 2017 Q2 | 380 Million JPY | -9.52% |
| 2017 Q1 | 420 Million JPY | -44.1% |
| 2016 Q1 | 736 Million JPY | -33.63% |
| 2016 FY | 751.32 Million JPY | -32.25% |
| 2016 Q4 | 751.32 Million JPY | 50.27% |
| 2016 Q3 | 500 Million JPY | -7.41% |
| 2016 Q2 | 540 Million JPY | -26.63% |
| 2015 Q2 | 892 Million JPY | -5.51% |
| 2015 FY | 1.1 Billion JPY | -18.37% |
| 2015 Q4 | 1.1 Billion JPY | 32.02% |
| 2015 Q1 | 944 Million JPY | -30.51% |
| 2015 Q3 | 840 Million JPY | -5.83% |
| 2014 FY | 1.35 Billion JPY | -12.57% |
| 2014 Q2 | 1.29 Billion JPY | -4.64% |
| 2014 Q4 | 1.35 Billion JPY | 4.31% |
| 2014 Q3 | 1.3 Billion JPY | 0.65% |
| 2014 Q1 | 1.35 Billion JPY | -12.67% |
| 2013 Q2 | 1.32 Billion JPY | -4.4% |
| 2013 Q3 | 1.26 Billion JPY | -4.61% |
| 2013 Q4 | 1.55 Billion JPY | 23.03% |
| 2013 FY | 1.55 Billion JPY | -16.5% |
| 2013 Q1 | 1.38 Billion JPY | -25.58% |
| 2012 Q3 | 1.48 Billion JPY | -3.2% |
| 2012 Q4 | 1.86 Billion JPY | 25.49% |
| 2012 Q2 | 1.53 Billion JPY | -3.1% |
| 2012 FY | 1.86 Billion JPY | 12.25% |
| 2012 Q1 | 1.58 Billion JPY | -4.64% |
| 2011 Q2 | 1.76 Billion JPY | 21.76% |
| 2011 FY | 1.65 Billion JPY | 12.7% |
| 2011 Q3 | 1.72 Billion JPY | -2.47% |
| 2011 Q1 | 1.45 Billion JPY | -1.36% |
| 2011 Q4 | 1.65 Billion JPY | -3.79% |
| 2010 Q4 | 1.47 Billion JPY | -1.35% |
| 2010 FY | 1.47 Billion JPY | -10.89% |
| 2010 Q1 | 1.59 Billion JPY | -3.61% |
| 2010 Q2 | 1.54 Billion JPY | -3.14% |
| 2010 Q3 | 1.49 Billion JPY | -3.25% |
| 2009 Q4 | 1.65 Billion JPY | 0.11% |
| 2009 Q3 | 1.64 Billion JPY | 23.09% |
| 2009 Q2 | 1.33 Billion JPY | 0.0% |
| 2009 FY | 1.65 Billion JPY | 5580.12% |
| 2008 Q3 | 75.34 Million JPY | 0.0% |
| 2008 Q4 | 29.06 Million JPY | -61.42% |
| 2008 FY | 29.06 Million JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |